156 results
8-K
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
5 Jan 24
Other Events
5:50pm
of factors including coverage and reimbursement levels from governmental authorities and health insurers as well as market acceptance by healthcare providers
8-K
EX-10.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
17 Oct 23
Entry into a Material Definitive Agreement
7:24pm
form regulated pursuant to any Environmental Law.
“Healthcare Laws” means, collectively, all local, state, federal, national, and supranational … , and foreign healthcare laws, manual provisions, policies and administrative guidance relating to the regulation of the Loan Parties including, without
S-3ASR
EX-1.2
dalkcfggz
30 Sep 22
Automatic shelf registration
4:17pm
8-K
EX-99.1
mi5 ondojc
29 Jun 22
Ligand Pharmaceuticals Appoints Jason Haas to its Board of Directors
5:17pm
8-K
2106vq4jkp1qy
29 Jun 22
Ligand Pharmaceuticals Appoints Jason Haas to its Board of Directors
5:17pm
425
EX-99.1
7vg43dgl2fz1fbshy6km
21 Jun 22
Business combination disclosure
8:00am
8-K
EX-99.1
r5tf20us
21 Jun 22
Regulation FD Disclosure
6:19am
425
2uk3si
24 Mar 22
Business combination disclosure
9:09am
8-K
EX-2.1
q8kvh07it4zgp
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
425
EX-99.3
71o1a fs5d2hdmh
23 Mar 22
Business combination disclosure
5:29pm
425
EX-99.1
bsxxb 8d9
23 Mar 22
Business combination disclosure
5:29pm
425
EX-99.2
9kxdijmp3rpniw h2s7
23 Mar 22
Business combination disclosure
5:29pm
8-K
EX-99.3
0kjeg7mk4q
23 Mar 22
Ligand to Spin-Off its OmniAb Business Through Merger with Avista Public Acquisition Corp. II
5:25pm
8-K
EX-99.1
cgugs3
23 Mar 22
Ligand to Spin-Off its OmniAb Business Through Merger with Avista Public Acquisition Corp. II
5:25pm